AT365189B - Verfahren zur herstellung von neuen trans-dl-5substituierten4,4a,5,6,7,8,8a,9-octahydro-2h-pyrrolo(3,4-g)-chinolinen und den salzen hiervon - Google Patents

Verfahren zur herstellung von neuen trans-dl-5substituierten4,4a,5,6,7,8,8a,9-octahydro-2h-pyrrolo(3,4-g)-chinolinen und den salzen hiervon

Info

Publication number
AT365189B
AT365189B AT0452579A AT452579A AT365189B AT 365189 B AT365189 B AT 365189B AT 0452579 A AT0452579 A AT 0452579A AT 452579 A AT452579 A AT 452579A AT 365189 B AT365189 B AT 365189B
Authority
AT
Austria
Prior art keywords
quinolines
octahydro
pyrrolo
salts
substituted
Prior art date
Application number
AT0452579A
Other languages
German (de)
English (en)
Other versions
ATA452579A (de
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/031,642 external-priority patent/US4235909A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to AT10781A priority Critical patent/AT371464B/de
Publication of ATA452579A publication Critical patent/ATA452579A/de
Application granted granted Critical
Publication of AT365189B publication Critical patent/AT365189B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT0452579A 1979-01-22 1979-06-28 Verfahren zur herstellung von neuen trans-dl-5substituierten4,4a,5,6,7,8,8a,9-octahydro-2h-pyrrolo(3,4-g)-chinolinen und den salzen hiervon AT365189B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT10781A AT371464B (de) 1979-01-22 1981-01-13 Verfahren zur herstellung von neuen trans-dl-4,4a,5,6,7,8,8a,9-octahydro-2h-pyrrolo 3,4-g)chinolin- verbindungen und ihren salzen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US506279A 1979-01-22 1979-01-22
US06/031,642 US4235909A (en) 1979-04-19 1979-04-19 Octahydro-2H-pyrrolo[3,4-g]quinolines

Publications (2)

Publication Number Publication Date
ATA452579A ATA452579A (de) 1981-05-15
AT365189B true AT365189B (de) 1981-12-28

Family

ID=26673871

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0452579A AT365189B (de) 1979-01-22 1979-06-28 Verfahren zur herstellung von neuen trans-dl-5substituierten4,4a,5,6,7,8,8a,9-octahydro-2h-pyrrolo(3,4-g)-chinolinen und den salzen hiervon

Country Status (25)

Country Link
EP (1) EP0013788B1 (US20100268047A1-20101021-C00003.png)
JP (1) JPS55100385A (US20100268047A1-20101021-C00003.png)
AR (1) AR225012A1 (US20100268047A1-20101021-C00003.png)
AT (1) AT365189B (US20100268047A1-20101021-C00003.png)
AU (1) AU528035B2 (US20100268047A1-20101021-C00003.png)
BE (1) BE877328A (US20100268047A1-20101021-C00003.png)
CA (1) CA1131227A (US20100268047A1-20101021-C00003.png)
CH (2) CH641801A5 (US20100268047A1-20101021-C00003.png)
DD (1) DD144668A5 (US20100268047A1-20101021-C00003.png)
DE (1) DE2965277D1 (US20100268047A1-20101021-C00003.png)
DK (1) DK268979A (US20100268047A1-20101021-C00003.png)
ES (1) ES482084A1 (US20100268047A1-20101021-C00003.png)
FI (1) FI65248C (US20100268047A1-20101021-C00003.png)
FR (2) FR2446833A1 (US20100268047A1-20101021-C00003.png)
GB (1) GB2040917B (US20100268047A1-20101021-C00003.png)
IE (1) IE48295B1 (US20100268047A1-20101021-C00003.png)
IL (1) IL57665A (US20100268047A1-20101021-C00003.png)
LU (1) LU81440A1 (US20100268047A1-20101021-C00003.png)
NZ (1) NZ190834A (US20100268047A1-20101021-C00003.png)
PH (2) PH15118A (US20100268047A1-20101021-C00003.png)
PL (1) PL125785B1 (US20100268047A1-20101021-C00003.png)
PT (1) PT69828A (US20100268047A1-20101021-C00003.png)
RO (1) RO77442A (US20100268047A1-20101021-C00003.png)
SU (1) SU1113006A3 (US20100268047A1-20101021-C00003.png)
ZA (1) ZA793244B (US20100268047A1-20101021-C00003.png)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL65269A0 (en) * 1981-03-24 1982-05-31 Lilly Co Eli 6-substituted hexahydroindazolo or hexahydroisoindolo isoquinolines
EP0127708B1 (en) * 1983-06-03 1987-09-09 Eli Lilly And Company Trans-dl-1-alkyl-6-alkoxyoctahydroquinolines
IL73001A0 (en) * 1983-09-26 1984-12-31 Lilly Co Eli Improvements in and relating to 6-oxodecahydroquinolines
US4595754A (en) * 1985-03-04 1986-06-17 Eli Lilly And Company Process for preparing cis N-alkylperhydroquinolines
AR067027A1 (es) * 2007-06-19 2009-09-30 Astrazeneca Ab Derivados de 2, 3-dihidro-1h-pirrol[3, 4b]quinolin-1-ona, una composicion farmaceutica que los comprende y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la modulacion de la actividad del receptor gaba a.
TWI537274B (zh) * 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途

Also Published As

Publication number Publication date
PH16181A (en) 1983-07-25
FI65248C (fi) 1984-04-10
FR2446835B1 (US20100268047A1-20101021-C00003.png) 1982-04-23
FR2446833B1 (US20100268047A1-20101021-C00003.png) 1982-03-05
GB2040917B (en) 1983-01-06
IE48295B1 (en) 1984-11-28
PL125785B1 (en) 1983-06-30
LU81440A1 (fr) 1979-09-12
AU4844479A (en) 1980-07-31
NZ190834A (en) 1984-07-06
DD144668A5 (de) 1980-10-29
JPS55100385A (en) 1980-07-31
PT69828A (en) 1979-07-01
DK268979A (da) 1980-07-23
PL216721A1 (US20100268047A1-20101021-C00003.png) 1980-06-16
BE877328A (fr) 1979-12-28
ZA793244B (en) 1981-02-25
CA1131227A (en) 1982-09-07
IL57665A (en) 1982-11-30
EP0013788B1 (en) 1983-04-27
PH15118A (en) 1982-08-10
FI65248B (fi) 1983-12-30
ATA452579A (de) 1981-05-15
CH641801A5 (fr) 1984-03-15
FI792047A (fi) 1980-07-23
IE791210L (en) 1980-10-19
DE2965277D1 (en) 1983-06-01
RO77442A (ro) 1982-10-26
GB2040917A (en) 1980-09-03
FR2446835A1 (fr) 1980-08-14
JPS6233233B2 (US20100268047A1-20101021-C00003.png) 1987-07-20
AR225012A1 (es) 1982-02-15
EP0013788A1 (en) 1980-08-06
SU1113006A3 (ru) 1984-09-07
ES482084A1 (es) 1980-08-01
CH643258A5 (fr) 1984-05-30
IL57665A0 (en) 1979-10-31
AU528035B2 (en) 1983-04-14
FR2446833A1 (fr) 1980-08-14

Similar Documents

Publication Publication Date Title
ATA63678A (de) Verfahren zur herstellung von neuen 1-(1,3dioxolan-2-ylmethyl)-1h-imidazolen und -1h-1,2,4- triaxolen und deren salzen
AT371819B (de) Verfahren zur herstellung von neuen trans-4,4a,5, 6,7,8,8a,9-octahydro-1h (und 2h)-pyrazolo(3,4-g) chinolinen, deren isomeren und den saeureadditionssalzen hiervon
AT369750B (de) Verfahren zur herstellung des neuen 11-aza-4-0cladinosyl-6-0-desosaminyl-15-aethyl-7,13,14-
AT363491B (de) Verfahren zur herstellung von neuen 1,3,8trisubstituierten xanthinen und deren salzen
AT357553B (de) Verfahren zur herstellung von neuen 2-(2,2- diarylalkyl)-1-azabicyclo(2.2.2)octanen und von deren salzen
ATA750879A (de) Verfahren zur herstellung von neuen 1,2,4,5-tetra--alkyl-4-aryl-piperidinen und ihren salzen
AT355018B (de) Verfahren zur herstellung von neuen 1,2- benzisothiazolinonen und von deren salzen
AT365189B (de) Verfahren zur herstellung von neuen trans-dl-5substituierten4,4a,5,6,7,8,8a,9-octahydro-2h-pyrrolo(3,4-g)-chinolinen und den salzen hiervon
AT365588B (de) Verfahren zur herstellung von neuen spiropyridochroman-4',5-hydantoinen
ATA419280A (de) Verfahren zur herstellung von neuen 1,1,2triphenyl-propan- und propen-derivaten
AT359070B (de) Verfahren zur herstellung von neuen 2,4-diamino -5-benzylpyrimidinen und deren salzen
ATA269579A (de) Verfahren zur herstellung von neuen 2,5-dihydro -1,2-thiazino-(5,6-b)indol-3-carboxamid-1,1- dioxiden und von deren salzen
AT352139B (de) Verfahren zur herstellung von neuen 2,9- dioxatricyclo-(4,3,1,03,7)decanen und deren salzen
AT346321B (de) Verfahren zur herstellung von neuen 4'- substituierten benzoylphenylnaphthalinen und den saeureadditionssalzen hievon
AT368754B (de) Verfahren zur herstellung von neuen acyl-1h-1,2,4-triazolderivaten und ihren salzen
AT364841B (de) Verfahren zur herstellung von neuen 1,2-benzisothiazolen und deren saeureadditionssalzen
AT384806B (de) Verfahren zur herstellung von neuen 4-aryl-2-methyl-1,2,3,4-tetrahydro-isochinolinderivaten und deren salzen
ATA91780A (de) Verfahren zur herstellung des neuen 2-benzyl-3(3-dimethylaminopropylthio)-2h-indazols und von dessen salzen
AT357148B (de) Verfahren zur herstellung von neuen 2,3-dihydro -2-oxo-thiophenderivaten und ihren salzen
AT361925B (de) Verfahren zur herstellung des neuen n-6-chlor- nicothinoyl-d,1-homocysteinthiolactons und dessen salzen
ATA278280A (de) Verfahren zur herstellung von neuen 4,5,6,7tetrahydroisoindolderivat und von deren salzen
ATA313783A (de) Verfahren zur herstellung von neuen 4,5,6,7tetrahydroisoindolderivaten und von deren salzen
ATA10781A (de) Verfahren zur herstellung von neuen trans-dl-4,4a,5,6,7,8,8a,9-octahydro-2h-pyrrolo 3,4-g)chinolin- verbindungen und ihren salzen
AT377258B (de) Verfahren zur herstellung von neuen 4-hydroxycumarin- und 1,3-indandion-derivaten
ATA42280A (de) Verfahren zur herstellung von neuen 2,4- -diamino-5-benzylpyrimidinen und deren salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee